The pharmaceutical industry develops drugs and interventions that benefit society, allowing us to live healthier, happier, more productive, and more fulfilling lives. Between 2000 and 2009, medicines contributed 73% of the 21-month life expectancy increase. Medicines have also led to 83% of survival gains in cancer, and prevented 862,000 deaths since the mid-90s in the United States alone.
However, these new medicines don’t come without a struggle, and pharma R&D remains one of the highest risk business areas. In fact, 85% of medicines in development fail to reach approval while 30% of marketed drugs don’t make enough money to cover their R&D costs.
Clinical and research excellence has numerous interpretations and definitions, ranging from the unwavering commitment to identify a cure for the rarest, unmet needs to demonstrated innovation or R&D effectiveness. At Pharma Intelligence, we both celebrate and support the dialogue.
The CARE Index
Based on a series of key R&D indicators that leverage our proprietary R&D data sets, Pharma Intelligence developed a definitive index of clinical and research excellence. The CARE Index also allows you to create your own version by adjusting indicator weightings to reflect what clinical and research excellence means to you, and compare this with ones created by our analysts and journalists.
The CARE Awards
The CARE Awards are dedicated to recognizing clinical achievements in the pharmaceutical industry. The awards showcase excellence in clinical trial design, technological advancements and results, as well as the outstanding achievements of individuals, departments, teams or organizations. Winners will have contributed to the advancement of therapies for unmet medical needs, undertaken ground-breaking collaborations, and contributed to positive clinical outcomes, with a focus on best practice and innovation.
Join us as we celebrate the CARE Awards winners during the ceremony that will be held in Boston in the State Room on Wednesday, April 5, 2017. We are still accepting entries until February 3, 2017 – Don’t miss out and enter here today!
